Physician profile
Zane Grant
NPI 1922770874
$2,119.32
in general payments reported to CMS, 2019-2025
18 companies · $91.17 in 2025
The $91.17 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $23.30 · 2022: $536 · 2023: $769 · 2024: $699 · 2025: $91.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,559 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,558.72 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $285.46 | 2022-2023 | Lybalvi, Vivitrol |
| Regeneron Healthcare Solutions, INC. | $227.91 | 2024 | Dupixent |
| Janssen Pharmaceuticals, INC | $196.01 | 2021-2023 | Invega Sustenna |
| Neurocrine Biosciences, INC. | $173.88 | 2022 | |
| Edwards Lifesciences Corporation | $142.73 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Silk Road Medical, INC. | $133.34 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Novo Nordisk INC | $125.00 | 2024 | |
| Aimmune Therapeutics, INC. | $124.98 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $123.79 | 2024 | Austedo Xr |
| Abbvie INC. | $123.79 | 2023 | |
| Shield Therapeutics INC | $123.79 | 2023 | Accrufer |
| Medtronic, INC. | $97.46 | 2024 | Intellis Adaptivestim |
| Sanofi-Aventis U.S. LLC | $81.98 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $50.10 | 2023 | |
| Glaxosmithkline, LLC. | $36.57 | 2025 | Bexsero, Shingrix, Arexvy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $27.36 | 2025 | Thinprep 2000 Processor, Aptima |
| Lilly USA, LLC | $27.24 | 2025 | Mounjaro, Zepbound |
| Cranial Technologies, INC | $17.93 | 2023 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zane Grant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.